Similar Articles
New Treatment Strategies in the Treatment of Juvenile Idiopathic Arthritis
İbrahim GÖKÇE, Erkan DEMİRKAYA
DOI: 10.5606/tjr.2011.012
The Reported Adverse Effects Related to Biological Agents Used for the Treatment of Rheumatic Diseases in Turkey
Erkan KILIÇ, Gamze KILIÇ, Özgür AKGÜL, Gürkan AKGÖL, Salih ÖZGÖÇMEN
DOI: 10.5606/tjr.2013.3052
The Off-Label Use of Rituximab for the Management of Inflammatory Disorders: American University of Beirut Medical Center Experience
Dana HARB, Hiba MOUKADEM, Rabih NAYFE, Ali MEHDI, Abdel Fattah MASRI, Ziad SALEM, Ali TAHER, Imad UTHMAN
DOI: 10.5606/ArchRheumatol.2014.3855
Aortic Valve Involvement in a Patient With Granulomatosis With Polyangiitis
Gurmeet SINGH, Surinder Kumar BALI, Varsha KOUL
DOI: 10.5606/ArchRheumatol.2014.4006
A Rare Kind of Lymphoma in a Patient on Treatment With Two Different Biological Agents
Inesa ARSTIKYTE, Irena BUTRIMIENE, Agne PETRULIONIENE, Algirdas VENALIS
DOI: 10.5606/ArchRheumatol.2015.4383
Immunoglobulin G4-Related Disease Presented as Recurrent Otitis Media and Mixed Hearing Loss Treated With Cyclophosphamide and Rituximab: A Case Report
Shao SAN, Chia-der LIN, Sheng-ta TSAI, Chao-chun LIN, Po-chang WU
DOI: 10.5606/ArchRheumatol.2019.7178
Efficacy of Rituximab for Refractory Pyoderma Gangrenosum-Like Ulcers in Granulomatosis With Polyangiitis Associated to Antiphospholipid Antibodies
Julia RIERA, Jorge MUSURUANA, Cecilia COSTA, Javier CAVALLASCA
DOI: 10.46497/ArchRheumatol.2020.7498
Rituximab for rheumatoid arthritis-related interstitial lung disease: A systematic review and meta-analysis
Tarun Krishna Boppana, Saurabh Mittal, Karan Madan, Anant Mohan, Vijay Hadda, Randeep Guleria
DOI: 10.46497/ArchRheumatol.2023.10199